Literature DB >> 1713300

Subcutaneous granulocyte colony-stimulating factor and acute anaphylaxis.

I Jaiyesimi, S S Giralt, J Wood.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1713300     DOI: 10.1056/NEJM199108223250818

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Systemic hypersensitivity reaction mimicking anaphylaxis after first filgrastim administration in a healthy donor.

Authors:  Ashok Tholpady; Ion Chiosea; Jonathan J Lyons; Kristin Baird; Susan F Leitman
Journal:  Transfusion       Date:  2013-05       Impact factor: 3.157

3.  Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor.

Authors:  Keita Yamamoto; Noriko Doki; Yasushi Senoo; Yuho Najima; Takeshi Kobayashi; Kazuhiko Kakihana; Kyoko Haraguchi; Yoshiki Okuyama; Hisashi Sakamaki; Kazuteru Ohashi
Journal:  Transfus Med Hemother       Date:  2016-10-18       Impact factor: 3.747

4.  The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization.

Authors:  Shu-Huey Chen; Shang-Hsien Yang; Sung-Chao Chu; Yu-Chieh Su; Chu-Yu Chang; Ya-Wen Chiu; Ruey-Ho Kao; Dian-Kun Li; Kuo-Liang Yang; Tso-Fu Wang
Journal:  Int J Hematol       Date:  2011-04-21       Impact factor: 2.490

Review 5.  Hematopoietic stem cell donation.

Authors:  Shu-Huey Chen; Tso-Fu Wang; Kuo-Liang Yang
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

Review 6.  Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.

Authors:  J E Frampton; C R Lee; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.